Literature DB >> 30573752

Risk of preterm and early term birth by maternal drug use.

Rebecca J Baer1,2, Christina D Chambers3, Kelli K Ryckman4, Scott P Oltman5,6, Larry Rand5,7, Laura L Jelliffe-Pawlowski5,6.   

Abstract

OBJECTIVE: Examine the risk of preterm birth (PTB, < 37 weeks) and early term birth (37-38 weeks) for women with reported drug abuse/dependence. STUDY
DESIGN: The population was drawn from singleton livebirths in California from 2007 to 2012. Drug abuse/dependence was determined from maternal diagnostic codes (opioid, cocaine, cannabis, amphetamine, other, or polysubstance). Relative risks, adjusted for maternal factors were calculated for PTB and early term birth. RESULT: Of the 2,890,555 women in the sample, 1.7% (n = 48,133) had a diagnostic code for drug abuse/dependence. The percentage of PTBs varied from 11.6% (cannabis) to 24.3% (cocaine), compared with 6.7% of women without reported drug abuse/dependence.
CONCLUSION: Women with reported drug abuse/dependence during pregnancy were at increased risk of having a PTB and all but those using cannabis were at risk of having an early term birth. Women using cocaine and polysubstance were at the highest risk of birth < 32 weeks.

Entities:  

Mesh:

Year:  2018        PMID: 30573752     DOI: 10.1038/s41372-018-0299-0

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

1.  The effect of cocaine abuse on birth weight and gestational age.

Authors:  M Chouteau; P B Namerow; P Leppert
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661

2.  A cohort study of alkaloidal cocaine ("crack") in pregnancy.

Authors:  R Cherukuri; H Minkoff; J Feldman; A Parekh; L Glass
Journal:  Obstet Gynecol       Date:  1988-08       Impact factor: 7.661

  2 in total
  8 in total

1.  Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy.

Authors:  Anna E Austin; Rebecca B Naumann; Elizabeth Simmons
Journal:  JAMA Pediatr       Date:  2022-09-19       Impact factor: 26.796

2.  Five-Year Outcomes Among Medicaid-Enrolled Children With In Utero Opioid Exposure.

Authors:  Marian P Jarlenski; Elizabeth E Krans; Joo Yeon Kim; Julie M Donohue; A Everette James; David Kelley; Bradley D Stein; Debra L Bogen
Journal:  Health Aff (Millwood)       Date:  2020-02       Impact factor: 6.301

3.  The risk of preterm birth among women with a history of leukemia or lymphoma.

Authors:  Sonia T Anand; Elizabeth A Chrischilles; Rebecca J Baer; Mary E Charlton; Patrick J Breheny; William W Terry; Monica R McLemore; Deborah A Karasek; Laura L Jelliffe-Pawlowski; Kelli K Ryckman
Journal:  J Matern Fetal Neonatal Med       Date:  2021-04-08

4.  The epidemiologic characteristics and associated risk factors of preterm birth from 2004 to 2013 in Taiwan.

Authors:  Yu-Kang Chang; Yuan-Tsung Tseng; Kow-Tong Chen
Journal:  BMC Pregnancy Childbirth       Date:  2020-04-06       Impact factor: 3.007

5.  Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers.

Authors:  Zoe King; Camille Kramer; Carl Latkin; Carolyn Sufrin
Journal:  J Subst Abuse Treat       Date:  2021-02-25

6.  The Negative Impact of Maternal Perinatal Opioid Use on Neonatal Outcomes.

Authors:  Kriti D Gandhi; Kathryn M Schak; Jennifer L Vande; Julia Shekunov; Brian A Lynch; Teresa A Rummans; Jennifer R Geske; Eric R Pease; Mara G Limbeck; Jinal Desai; Paul E Croarkin; Magdalena Romanowicz
Journal:  Prim Care Companion CNS Disord       Date:  2021-06-10

7.  Update on the developmental consequences of cannabis use during pregnancy and lactation.

Authors:  Kimberly S Grant; Elizabeth Conover; Christina D Chambers
Journal:  Birth Defects Res       Date:  2020-08-07       Impact factor: 2.661

8.  Marijuana Use during Pregnancy and Preterm Birth: A Prospective Cohort Study.

Authors:  Mark A Klebanoff; Diana G Wilkins; Sarah A Keim
Journal:  Am J Perinatol       Date:  2020-04-01       Impact factor: 3.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.